INS and metabolic dysfunction-associated steatotic liver disease: Importantly, SHTG often coexists with metabolic dysfunction-associated steatotic liver disease (MASLD) [24,25,26], reflecting a bidirectional relationship between hepatic insulin resistance, steatosis, and impaired clearance of triglyceride-rich lipoproteins.